Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Change in composition of inflammatory infiltrate in the course of hepatitis C reinfection and concomitant acute rejection after orthotopic liver transplantation.

Ziarkiewicz-Wróblewska B, Wróblewski T, Ciszek M, Kalinowski P, Malejczyk J.

Ann Transplant. 2014 Jan 24;19:41-50. doi: 10.12659/AOT.884034.

2.

Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study.

Guerrero RB, Batts KP, Burgart LJ, Barrett SL, Germer JJ, Poterucha JJ, Wiesner RH, Charlton MR, Persing DH.

Mod Pathol. 2000 Mar;13(3):229-37.

3.

Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation.

Petrovic LM, Villamil FG, Vierling JM, Makowka L, Geller SA.

Liver Transpl Surg. 1997 Jul;3(4):398-406.

4.

(Cleaved) CK18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allografts.

Reis H, Wohlschläger J, Hagemann S, Wenzel P, Bechmann LP, Suttorp AC, Schlattjan MJ, Herzer K, Canbay A, Baba HA.

Liver Int. 2015 Mar;35(3):905-13. doi: 10.1111/liv.12572. Epub 2014 May 12.

PMID:
24750688
5.

Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.

Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.

Am J Gastroenterol. 1997 Sep;92(9):1453-7.

PMID:
9317061
6.

C4d in acute rejection after liver transplantation and its usefulness in differential diagnosis between acute liver rejection and hepatitis C recurrence.

Gierej B, Kobryń K, Gierej P, Górnicka B.

Ann Transplant. 2014 Aug 1;19:373-81. doi: 10.12659/AOT.890234.

7.
8.

Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.

Bizollon T, Ahmed SN, Guichard S, Chevallier P, Adham M, Ducerf C, Baulieux J, Trepo C.

Gut. 2000 Nov;47(5):698-702.

9.

[A clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B virus infection].

Pei F, Zheng J, Du J, Zhong HH, Yang JP.

Beijing Da Xue Xue Bao. 2008 Aug 18;40(4):408-14. Chinese.

10.

Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver.

Ballardini G, De Raffele E, Groff P, Bioulac-Sage P, Grassi A, Ghetti S, Susca M, Strazzabosco M, Bellusci R, Iemmolo RM, Grazi G, Zauli D, Cavallari A, Bianchi FB.

Liver Transpl. 2002 Jan;8(1):10-20.

11.

Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.

D'Errico-Grigioni A, Fiorentino M, Vasuri F, Gruppioni E, Fabbrizio B, Zucchini N, Ballardini G, Morelli C, Pinna AD, Grigioni WF.

Liver Transpl. 2008 Mar;14(3):313-20. doi: 10.1002/lt.21375.

12.

The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation.

Teixeira R, Pastacaldi S, Davies S, Dhillon AP, Emery VC, Rolles K, Davidson B, Patch D, Burroughs AK.

Transplantation. 2000 Nov 27;70(10):1454-8.

PMID:
11118089
13.

C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence.

Schmeding M, Dankof A, Krenn V, Krukemeyer MG, Koch M, Spinelli A, Langrehr JM, Neumann UP, Neuhaus P.

Am J Transplant. 2006 Mar;6(3):523-30.

14.

Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies.

Jain A, Ryan C, Mohanka R, Orloff M, Abt P, Romano J, Bryan L, Batzold P, Mantry P, Bozorgzadeh A.

Clin Transplant. 2006 Sep-Oct;20(5):624-33.

PMID:
16968489
15.

Apoptosis and the expression of Fas and Fas ligand (FasL) antigen in rejection and reinfection in liver allograft specimens.

Tannapfel A, Kohlhaw K, Ebelt J, Hauss J, Liebert U, Berr F, Wittekind C.

Transplantation. 1999 Apr 15;67(7):1079-83.

PMID:
10221500
16.

Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation.

Yedibela S, Schuppan D, Müller V, Schellerer V, Tannapfel A, Hohenberger W, Meyer T.

Liver Int. 2005 Aug;25(4):717-22.

PMID:
15998420
17.

Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.

Zekry A, Bishop GA, Bowen DG, Gleeson MM, Guney S, Painter DM, McCaughan GW.

Liver Transpl. 2002 Mar;8(3):292-301.

18.

Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

Grassi A, Ballardini G.

World J Gastroenterol. 2014 Aug 28;20(32):11095-115. doi: 10.3748/wjg.v20.i32.11095. Review.

19.

Graft loss following liver transplantation in patients with chronic hepatitis C.

Rosen HR, O'Reilly PM, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, Martin P.

Transplantation. 1996 Dec 27;62(12):1773-6.

PMID:
8990361
20.

Hepatitis viruses and liver transplantation.

Samuel D, Feray C, Bismuth H.

J Gastroenterol Hepatol. 1997 Oct;12(9-10):S335-41. Review.

PMID:
9407355
Items per page

Supplemental Content

Write to the Help Desk